United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 5 mg in 5 ml

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 356.4 mg

United States - English - NLM (National Library of Medicine)

caraco pharma inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - aspirin 356.4 mg

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - valproic acid (unii: 614oi1z5wi) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg in 5 ml - valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. complex absence is the term used when other signs are also present. see warnings and precautions (5.1) for statement regarding fatal hepatic dysfunction. valproic acid should not be administered to patients with hepatic disease or significant hepatic dysfunction [see warnings and precautions (5.1)] . valproic acid is contraindicated in patients with known hypersensitivity to the drug [see warnings and precautions (5.

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries limited - amifostine (unii: m487qf2f4v) (amifostine - unii:m487qf2f4v) - amifostine 50 mg in 1 ml

United States - English - NLM (National Library of Medicine)

pharmaceutica north america, inc. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 300 mg

United States - English - NLM (National Library of Medicine)

st marys medical park pharmacy - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 800 mg

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - risperidone (unii: l6uh7zf8hc) (risperidone - unii:l6uh7zf8hc) - risperidone 0.25 mg

United States - English - NLM (National Library of Medicine)

direct rx - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 40 mg - citalopram hbr, usp is indicated for the treatment of depression. the efficacy of citalopram tablets, usp in the treatment of depression was established in 4-6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-lll and dsm-lll-r category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets, usp in hospitalized depressed patients has not been adequately stud

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 20 mg